Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

Food naturally boosts your body’s GLP-1 levels, explained Dr. Sun Kim, an endocrinologist at Stanford Health Care in ...

While prescriptions for GLP-1 meds more than doubled between 2022 and 2023 (a rise of 132.6%), rates of bariatric surgery ...

However, the number of verified aspiration events came out to just 20 events, all identified from anesthesia notes and all in ...

When food enters the digestive system, specialized cells in the small intestine release GLP-1, initiating a cascade of ...

The American Heart Association and the American Stroke Association updated guidelines for the primary prevention of stroke, ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.